Breast Cancer, HER2
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Prevalence and Clinicopathologic Features of Different HER2 Level in Chinese Breast Cancer Patients (NCT05203458) | AstraZeneca | 2022-02-24 |
Track Breast Cancer, HER2 automatically
Every clearance here is in the API, with alerts when new ones post.